– Risk-Based Monitoring Solution Recognized at SCDM Annual Conference –
BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical Solutions, today announced that its Compass technology, a risk-based monitoring solution that improves overall quality in clinical trials, has won the inaugural Society for Clinical Data Management (SCDM) NextGen Technology Innovation (TIA) Award, presented as part of SCDM's 2014 annual conference.
BioClinica's entry utilizes "Intelligent Monitoring" to transform the way clinical trials are managed. Compass focuses on meaningful data, critical to the success of a trial, and makes it easy to view the overall performance of trial sites. Compass leverages intelligent monitoring to track trial performance and identify performance issues across sites and ensure the most efficient and effective use of resources.
Courtney McBean presents Compass to the SCDM Audience as part of the NextGen Awards competition.
The SCDM Award recognizes breakthrough innovations which use novel technologies or processes and provide real-life application for use in clinical trials. Compass, along with entrees from Maxisit and PHT, was chosen as a finalist from a broad field of entries. Courtney McBean, BioClinica's Vice President of Clinical Innovation, presented Compass to an enthusiastic SCDM audience as part of the competition.
"On behalf of SCDM, I would like to congratulate BioClinica on winning our inaugural NextGen Technology Innovation Award and thank all of our participating companies for their entries," said Derek Perrin, SCDM Vice-Chair. "Compass is exactly the kind of technology solution we want to highlight with this award. It is an innovative solution to meeting the newest challenge in clinical trials."
"This award not only recognizes the value Compass brings to clinical research, it also represents the clinical trial community's interest and willingness to embrace a new approach to monitoring," said BioClinica CEO Mark Weinstein. "The FDA has made it clear – we should be focusing our attention on the data that matters most – and Compass is a valuable tool to help trial sponsors accomplish this objective."
Courtney McBean will participate in a Risk-Based Monitoring panel at the upcoming Partnerships in Clinical Trials Europe conference in Barcelona, Spain. She will also be presenting a webinar to the clinical trial industry titled An Intelligent Approach to Risk-Based Monitoring - How People, Process and Tools can Improve Clinical Trial Quality on November 13th.
Other upcoming industry events where BioClinica is participating include:
- Outsourcing in Clinical Trials New England 2014
- 5th DIA Cardiac Safety Workshop in Japan
- Partnerships in Clinical Trials Europe
- DIA Japan Annual Meeting 2014
- Asia Clinical Trial Leader's Summit
- 7th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference
At each of these conferences, attendees will have an opportunity to converse with knowledgeable BioClinica representatives on latest trends in clinical trials and see live product demonstrations. To request a meeting with BioClinica during any of these events, call our hotline at 1-888-392-7456, email firstname.lastname@example.org or use our online Contact Us form.